Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

Last year, sales of obesity treatments surpassed Keytruda, the immune anticancer drug that had long held the top sales ...

The health reset that began in India after COVID-19 is no longer just about avoiding illness. It has quietly evolved into something deeper and more intentional. As we enter the second quarter of the ...

Moderna pivots to infectious disease & oncology, targeting cash break-even by 2028. Click here to see why I rate MRNA stock a ...

A new pizza spot is setting up shop on Manhattan’s Lower East Side, Commercial Observer has learned. “Quality operators like NYC Thin Crust recognize the corridor’s momentum, and our ability to secure ...

To promote its newly launched nonhormonal menopause drug, Bayer is linking Lynkuet with a familiar face. The Big Pharma has recruited Gabrielle Union-Wade to serve as a celebrity endorser for the ...

Merck & Co. is buying the developer of an experimental antiviral drug designed to prevent the flu, as the drugmaker aims to counter sales cliffs for two of its biggest drugs. Merck has been vocal ...

Optune Lua adoption lag hit shares, but 2026 catalysts and $230M net cash could drive a rebound. Know more about NVCR stock here.

The type of suppository you need—rectal, vaginal, or urethral—depends on your condition. Suppositories deliver medications directly into your body to treat conditions like constipation or vaginal ...

You may use D-mannose to help prevent UTIs by stopping bacteria from sticking to your urinary tract. It is generally safe for you to take D-mannose for up to six months, but speak with a doctor before ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Myles is a former senior insurance editor for Investopedia. He oversaw the strategy ...